Difference between revisions of "Part:BBa K3139007"
| (One intermediate revision by one other user not shown) | |||
| Line 5: | Line 5: | ||
A synthetic short peptide that cleaves the cell membrane of plasmodium. Leading inhibition of plasmodium development during the mozygotic phase. Users can make combination of different kinds and copies of anti-plasmodium peptides, with TEVp cleavage sites in between them, it could be cutted into different sizes of fragments. Each fragment could be effective to plasmodium. | A synthetic short peptide that cleaves the cell membrane of plasmodium. Leading inhibition of plasmodium development during the mozygotic phase. Users can make combination of different kinds and copies of anti-plasmodium peptides, with TEVp cleavage sites in between them, it could be cutted into different sizes of fragments. Each fragment could be effective to plasmodium. | ||
| − | + | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| + | The mechanism of killing Plasmodium is to contact with the cells and lyse them. | ||
<!-- --> | <!-- --> | ||
Latest revision as of 07:51, 21 October 2019
Anti-plasmodium peptide Vida3
A synthetic short peptide that cleaves the cell membrane of plasmodium. Leading inhibition of plasmodium development during the mozygotic phase. Users can make combination of different kinds and copies of anti-plasmodium peptides, with TEVp cleavage sites in between them, it could be cutted into different sizes of fragments. Each fragment could be effective to plasmodium.
Usage and Biology
The mechanism of killing Plasmodium is to contact with the cells and lyse them.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]